Trial intelligence / Profile preview

Bioequivalence of Newly Formulated Tylenol vs Tylenol 8H ER

NCT04230252Phase 1Completed

Sponsor
Janssen Pharmaceutical
Start
Jan 2020
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of acetaminophen in pain and fever (2 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Maximum Observed Analyte Concentration and Area Under the Concentration-time Curve From Time 0 to Last Measurable Concentration. Started Jan 2020; status: completed.

02

Drugs

acetaminophen
03

Conditions

painfever

Beyond the preview

Go deeper on NCT04230252.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04230252.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call